Frequency: Quarterly E- ISSN: Awaited P- ISSN: Abstracted/ Indexed in: Ulrich's International Periodical Directory, Google Scholar, SCIRUS, getCITED, Genamics JournalSeek, EBSCO Information Services
Quarterly published in print and online "Inventi Rapid: Oncology (Formerly Inventi Rapid: Cancer)" publishes high quality unpublished as well as high impact pre-published research and reviews catering to the needs of researchers and professionals. This journal focuses on all the aspects of oncology including etiology, course, and treatments of cancer. Aimed at the broader audience the journal accomplishes the objectives by facilitating the transfer of knowledge from the laboratory to the bedside; by contributing to cancer prevention, early detection, diagnosis, cure, and rehabilitation.
In the past few years, a lot of progress has been made in understanding how cancer might develop and how to treat it. Cancer is still hard to treat in the 21st century, though, because the number of people who get it is going up. Radiation therapy, surgery, chemotherapy, immunotherapy and hormonal therapy are all ways to treat cancer. Radiation therapy is still an important part of treating cancer. About half of all cancer patients get radiation therapy at some point during their illness and it makes up about 40% of treatments that cure cancer. The main goal of radiation therapy is to stop cancer cells from dividing and making more cancer cells. In the UK, 2011 has been named the year of radiation therapy to mark a century of progress since Marie Curie won her second Nobel Prize for her work on radium. Over the last 100 years, there have been constant improvements in how radiation is used to treat cancer and scientists have learned more about how cancer cells react to radiation. These improvements will help cancer patients live longer and have fewer side effects from treatment. In this review, we converse about radiation therapy's basic ideas, how it is used and how it has changed over time, as well as its biological effects....
Cervical cancer is common type of cancer that seen in woman now-a-days. Most of woman in developing countries like America, Africa, South and East Asia are prone to this type of cancer. It became the most common reason for death of women. Death happens due to failure to initiate or to go through certain cytology based screening programs. Majorly it causes because of human papilloma virus (HPV). It transmits through sexual contact. By histological studies of tissue isolated by biopsy disease is confirmed. Treatment for increase the life span can be given but complete curing cannot be done. Care should be taken to prevent the disease....
This letter to the editor is an effort to bring to the notice of the people of the growing concern regarding the most common cancer among females in India, i.e. Breast cancer. Breast Cancer also known as Breast carcinoma, is the carcinoma of the breast region among mostly females and few men. Cancer is actually the uncontrolled growth of cells, which ultimately leads to the toxic changes in the patients body, leading to the morbidity or in most cases mortalities. Breast cancer awareness among Indian population in both Educated and Uneducated people is highly low due to the lack of knowledge, taboo associated with the region of cancer in the country, and due to lack of importance towards the seriousness of the disease among the Indian mindsets, towards to causes of disease occurrence and dangers associated with particularly this type of cancer in the country. Breast cancer at present and in current scenario is the number one cancer among females in India above cervical cancer and by 2030, India will become Breast cancer capital of the world, after being already cardiovascular diseases capital of the world. Looking at the situation the current paper is an effort to increase the importance of giving attention to this rising dangerous disease or ailment among the Indians and also globally....
Anti-cancer drugs are the drugs especially researched and developed to kill the growing cancer cells, tumour cells, and the malignancies generated in the body or any part of the body. Cancer is globally the leading cause of death apart from heart diseases which is currently the number one disease leading to the majority of morbidity and mortality among the people globally. The first anti-cancer drug or the anti-neoplastic drug was discovered in the ninteenth centuries. And later further advance research and developments to fight the cancer are happening all across the globe. The first documented anti-cancer drug dates back to the year 1861, where Robert Bentley, from Kings College London, worked on local anti-tumour effects in Podophyllum peltatum. The extracts from this plant were even listed, in “Materia Medica”. The current letter is dedicated to famous chemotherapy drug, i.e. CYCLOPHOSPHAMIDE, CP. Cyclophosphamide, is a nitrogen class of chemotherapy drug, which works by alkylating the DNA strands of the cancer cells, and ultimately eliminates the malignancy. It was discovered and approved by FDA for cancer treatment in 1950’s. And has since been widely used as Chemotherapy drug worldwide...
Due to the limited therapeutic index and the intrinsic toxicity of anticancer drugs, drug reactions in oncology are of special concern. Interactions with other drugs could trigger slight differences in the chemotherapy agent's pharmacokinetics or pharmacodynamic, which may dramatically affect its effectiveness or toxicity. Precise data are not available, but the occurrence of drug-drug interactions in oncology is theorized to be higher than in most other conditions. The identification of potentially clinically important drug reactions has been made possible by advances in in-vitro approaches and early clinical research. Typically, cancer patients take a number of medications to manage related conditions, such as pain and nausea. The types of drug interactions that arise in oncology, the pathways causing these interactions and selected examples are illustrated....
Breast cancer, is a carcinoma in the region of breast of both males and females, however, it is highly common in females. Globally around 2 million cases are detected and diagnosed of breast cancer, with India becoming the epicentre of the newly emerging cases compared to the world. There is still lot of hesitations among Indian women to go for early diagnosis, a stage where it is highly treatable and has good prognosis. There are various reasons for the development of breast cancer and also there are various types of breast cancer depending upon the characteristics of the cancer. Most common types are ER PR positive/ Her2 negative (considered as good cancer) and Totally Her2 Positive or Triple positive (where the prognosis becomes little difficult). Breast cancer has various types depending upon the region its occurring and the patho-physiological changes happening due to the development of the cancer. Signaling pathways are the pathways any particular type of cancer develops in the body and it plays a significant role in the stage and development of cancer. Also signaling pathways are the outside environment of the cell which decides the type and prognosis of the cancer. Recent, researches are happening globally to develop targeted therapies for breast cancer, depending upon the signaling pathways any particular type of cancer follows to develop and progress in the body. Hence, this review has been written in order to attract the specific attention of the researchers to be aware of the signaling pathways present in any cases of breast cancer and personalized treatment plan can be followed in order to save the precious lives....
Loading....